We wrote about Cabot Corporation (NYSE: CBT ) in May of last year when we doubled down on our bullish rating in the specialty chemicals & performance materials enterprise. The stock was trading at approximately the $101 level at the time. Although the company'sIndividual investor with a keen interest in deriving income from investment setups. We do this by buying undervalued profitable stocks with strong balance sheets & minimal debt. Furthermore, when the opportunity arises, we like to write calls against ...